APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidiuretic Hormone (ADH) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antidiuretic Hormone (ADH) Drug Market Analysis and Forecast 2026-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchAntidiuretic Hormone (ADH) Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiuretic Hormone (ADH) Drug Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Antidiuretic Hormone (ADH) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiuretic Hormone (ADH) Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiuretic Hormone (ADH) Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Antidiuretic Hormone (ADH) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antidiuretic Hormone (ADH) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antidiuretic Hormone (ADH) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antidiuretic Hormone (ADH) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antidiuretic Hormone (ADH) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antidiuretic Hormone (ADH) Drug include Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, Fresenius Kabi, Ferring Pharmaceuticals, Endo International and Cumberland Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antidiuretic Hormone (ADH) Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antidiuretic Hormone (ADH) Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Antidiuretic Hormone (ADH) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antidiuretic Hormone (ADH) Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antidiuretic Hormone (ADH) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antidiuretic Hormone (ADH) Drug revenue, projected growth trends, production technology, application and end-user industry.

Antidiuretic Hormone (ADH) Drug Segment by Company

Hybio Pharmaceutical

Hainan Zhonghe Pharmaceutical

Fresenius Kabi

Ferring Pharmaceuticals

Endo International

Cumberland Pharmaceuticals

Antidiuretic Hormone (ADH) Drug Segment by Type

Premixed Solution

Injection

Antidiuretic Hormone (ADH) Drug Segment by Application

Diabetes Insipidus

Vasodilatory Shock

Others

Antidiuretic Hormone (ADH) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antidiuretic Hormone (ADH) Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antidiuretic Hormone (ADH) Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidiuretic Hormone (ADH) Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antidiuretic Hormone (ADH) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Premixed Solution Major Player Table 3. Injection Major Player Table 4. Global Antidiuretic Hormone (ADH) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diabetes Insipidus Major Player Table 6. Vasodilatory Shock Major Player Table 7. Others Major Player Table 8. Antidiuretic Hormone (ADH) Drug Industry Trends Table 9. Antidiuretic Hormone (ADH) Drug Industry Drivers Table 10. Antidiuretic Hormone (ADH) Drug Industry Opportunities and Challenges Table 11. Antidiuretic Hormone (ADH) Drug Industry Restraints Table 12. Global Antidiuretic Hormone (ADH) Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Antidiuretic Hormone (ADH) Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Antidiuretic Hormone (ADH) Drug Market Share by Region (2021-2026) Table 15. Global Antidiuretic Hormone (ADH) Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Antidiuretic Hormone (ADH) Drug Market Share by Region (2027-2032) Table 17. Global Antidiuretic Hormone (ADH) Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Players (2021-2026) Table 19. Global Antidiuretic Hormone (ADH) Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Antidiuretic Hormone (ADH) Drug Key Players Headquarters & Area Served Table 21. Global Antidiuretic Hormone (ADH) Drug Players, Product Type & Application Table 22. Global Antidiuretic Hormone (ADH) Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Antidiuretic Hormone (ADH) Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Antidiuretic Hormone (ADH) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Type (2021-2026) Table 29. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Type (2027-2032) Table 30. Global Antidiuretic Hormone (ADH) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Application (2021-2026) Table 34. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Application (2027-2032) Table 35. Hybio Pharmaceutical Company Information Table 36. Hybio Pharmaceutical Business Overview Table 37. Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio Table 39. Hybio Pharmaceutical Recent Development Table 40. Hainan Zhonghe Pharmaceutical Company Information Table 41. Hainan Zhonghe Pharmaceutical Business Overview Table 42. Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio Table 44. Hainan Zhonghe Pharmaceutical Recent Development Table 45. Fresenius Kabi Company Information Table 46. Fresenius Kabi Business Overview Table 47. Fresenius Kabi Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Fresenius Kabi Antidiuretic Hormone (ADH) Drug Product Portfolio Table 49. Fresenius Kabi Recent Development Table 50. Ferring Pharmaceuticals Company Information Table 51. Ferring Pharmaceuticals Business Overview Table 52. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio Table 54. Ferring Pharmaceuticals Recent Development Table 55. Endo International Company Information Table 56. Endo International Business Overview Table 57. Endo International Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Endo International Antidiuretic Hormone (ADH) Drug Product Portfolio Table 59. Endo International Recent Development Table 60. Cumberland Pharmaceuticals Company Information Table 61. Cumberland Pharmaceuticals Business Overview Table 62. Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio Table 64. Cumberland Pharmaceuticals Recent Development Table 65. North America Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 66. North America Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 67. North America Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Antidiuretic Hormone (ADH) Drug Revenue by Country (US$ Million) & (2027-2032) Table 72. Europe Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 73. Europe Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 74. Europe Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 75. Europe Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 76. Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026) & (US$ Million) Table 78. Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (US$ Million) & (2027-2032) Table 79. China Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 80. China Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 81. China Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 82. China Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 84. Asia Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 85. Asia Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 86. Asia Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Antidiuretic Hormone (ADH) Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Antidiuretic Hormone (ADH) Drug Revenue by Region (US$ Million) & (2021-2026) Table 89. Asia Antidiuretic Hormone (ADH) Drug Revenue by Region (US$ Million) & (2027-2032) Table 90. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026) & (US$ Million) Table 91. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032) & (US$ Million) Table 92. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026) & (US$ Million) Table 93. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032) & (US$ Million) Table 94. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (US$ Million) & (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Antidiuretic Hormone (ADH) Drug Image Figure 2. Global Antidiuretic Hormone (ADH) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiuretic Hormone (ADH) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Premixed Solution Image Figure 5. Injection Image Figure 6. Global Antidiuretic Hormone (ADH) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antidiuretic Hormone (ADH) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diabetes Insipidus Image Figure 9. Vasodilatory Shock Image Figure 10. Others Image Figure 11. Global Antidiuretic Hormone (ADH) Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Antidiuretic Hormone (ADH) Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antidiuretic Hormone (ADH) Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Antidiuretic Hormone (ADH) Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Antidiuretic Hormone (ADH) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Antidiuretic Hormone (ADH) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032) Figure 24. North America Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032) Figure 25. North America Antidiuretic Hormone (ADH) Drug Revenue Share by Country (2021-2032) Figure 26. United States Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032) Figure 31. Europe Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032) Figure 32. Europe Antidiuretic Hormone (ADH) Drug Revenue Share by Country (2021-2032) Figure 33. Germany Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032) Figure 43. China Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032) Figure 44. Asia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032) Figure 46. Asia Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032) Figure 47. Asia Antidiuretic Hormone (ADH) Drug Revenue Share by Region (2021-2032) Figure 48. Japan Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Antidiuretic Hormone (ADH) Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Antidiuretic Hormone (ADH) Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Premixed Solution
  • Injection
Applications
  • Diabetes Insipidus
  • Vasodilatory Shock
  • Others
Companies covered
  • Hybio Pharmaceutical
  • Hainan Zhonghe Pharmaceutical
  • Fresenius Kabi
  • Ferring Pharmaceuticals
  • Endo International
  • Cumberland Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antidiuretic Hormone (ADH) Drug Market by Type
  3. 1.2.1 Global Antidiuretic Hormone (ADH) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Premixed Solution
  5. 1.2.3 Injection
  6. 1.3 Antidiuretic Hormone (ADH) Drug Market by Application
  7. 1.3.1 Global Antidiuretic Hormone (ADH) Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diabetes Insipidus
  9. 1.3.3 Vasodilatory Shock
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Antidiuretic Hormone (ADH) Drug Market Dynamics
  1. 2.1 Antidiuretic Hormone (ADH) Drug Industry Trends
  2. 2.2 Antidiuretic Hormone (ADH) Drug Industry Drivers
  3. 2.3 Antidiuretic Hormone (ADH) Drug Industry Opportunities and Challenges
  4. 2.4 Antidiuretic Hormone (ADH) Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antidiuretic Hormone (ADH) Drug Market Perspective (2021-2032)
  2. 3.2 Global Antidiuretic Hormone (ADH) Drug Growth Trends by Region
  3. 3.2.1 Global Antidiuretic Hormone (ADH) Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antidiuretic Hormone (ADH) Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Antidiuretic Hormone (ADH) Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antidiuretic Hormone (ADH) Drug Revenue by Players
  2. 4.1.1 Global Antidiuretic Hormone (ADH) Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antidiuretic Hormone (ADH) Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antidiuretic Hormone (ADH) Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antidiuretic Hormone (ADH) Drug Key Players Headquarters & Area Served
  7. 4.4 Global Antidiuretic Hormone (ADH) Drug Players, Product Type & Application
  8. 4.5 Global Antidiuretic Hormone (ADH) Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antidiuretic Hormone (ADH) Drug Market CR5 and HHI
  11. 4.6.3 2025 Antidiuretic Hormone (ADH) Drug Tier 1, Tier 2, and Tier 3
5 Antidiuretic Hormone (ADH) Drug Market Size by Type
  1. 5.1 Global Antidiuretic Hormone (ADH) Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 5.3 Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Type (2021-2032)
6 Antidiuretic Hormone (ADH) Drug Market Size by Application
  1. 6.1 Global Antidiuretic Hormone (ADH) Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  3. 6.3 Global Antidiuretic Hormone (ADH) Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hybio Pharmaceutical
  2. 7.1.1 Hybio Pharmaceutical Company Information
  3. 7.1.2 Hybio Pharmaceutical Business Overview
  4. 7.1.3 Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio
  6. 7.1.5 Hybio Pharmaceutical Recent Developments
  7. 7.2 Hainan Zhonghe Pharmaceutical
  8. 7.2.1 Hainan Zhonghe Pharmaceutical Company Information
  9. 7.2.2 Hainan Zhonghe Pharmaceutical Business Overview
  10. 7.2.3 Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio
  12. 7.2.5 Hainan Zhonghe Pharmaceutical Recent Developments
  13. 7.3 Fresenius Kabi
  14. 7.3.1 Fresenius Kabi Company Information
  15. 7.3.2 Fresenius Kabi Business Overview
  16. 7.3.3 Fresenius Kabi Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Kabi Antidiuretic Hormone (ADH) Drug Product Portfolio
  18. 7.3.5 Fresenius Kabi Recent Developments
  19. 7.4 Ferring Pharmaceuticals
  20. 7.4.1 Ferring Pharmaceuticals Company Information
  21. 7.4.2 Ferring Pharmaceuticals Business Overview
  22. 7.4.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio
  24. 7.4.5 Ferring Pharmaceuticals Recent Developments
  25. 7.5 Endo International
  26. 7.5.1 Endo International Company Information
  27. 7.5.2 Endo International Business Overview
  28. 7.5.3 Endo International Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Endo International Antidiuretic Hormone (ADH) Drug Product Portfolio
  30. 7.5.5 Endo International Recent Developments
  31. 7.6 Cumberland Pharmaceuticals
  32. 7.6.1 Cumberland Pharmaceuticals Company Information
  33. 7.6.2 Cumberland Pharmaceuticals Business Overview
  34. 7.6.3 Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio
  36. 7.6.5 Cumberland Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Antidiuretic Hormone (ADH) Drug Revenue (2021-2032)
  2. 8.2 North America Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032)
  5. 8.3 North America Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032)
  9. 8.5 North America Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Antidiuretic Hormone (ADH) Drug Revenue by Country
  11. 8.6.1 North America Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Antidiuretic Hormone (ADH) Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Antidiuretic Hormone (ADH) Drug Revenue (2021-2032)
  2. 9.2 Europe Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antidiuretic Hormone (ADH) Drug Revenue by Country
  11. 9.6.1 Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antidiuretic Hormone (ADH) Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Antidiuretic Hormone (ADH) Drug Revenue (2021-2032)
  2. 10.2 China Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032)
  5. 10.3 China Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032)
  9. 10.5 China Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antidiuretic Hormone (ADH) Drug Revenue (2021-2032)
  2. 11.2 Asia Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antidiuretic Hormone (ADH) Drug Revenue by Country
  11. 11.6.1 Asia Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antidiuretic Hormone (ADH) Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antidiuretic Hormone (ADH) Drug Revenue (2021-2032)
  2. 12.2 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antidiuretic Hormone (ADH) Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antidiuretic Hormone (ADH) Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country
  11. 12.6.1 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antidiuretic Hormone (ADH) Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst